electroCore Partners with iHeartRadio and Former New York Jets Star Linebacker Greg Buttle to Champion Better Sleep and Stress Relief
electroCore (NASDAQ: ECOR) has announced a partnership with former New York Jets linebacker Greg Buttle to promote Truvaga™ Plus, their next-generation vagus nerve stimulation (nVNS) device. The partnership aims to raise awareness about the device's benefits for sleep improvement and stress relief.
Truvaga is a portable wellness device that stimulates the vagus nerve in two-minute sessions, helping users achieve better sleep and relaxation without medication. The partnership includes radio spots and digital campaigns, leveraging Buttle's NFL experience and broadcasting background to showcase how Truvaga supports stress management and sleep quality.
electroCore (NASDAQ: ECOR) ha annunciato una collaborazione con l'ex linebacker dei New York Jets Greg Buttle per promuovere Truvaga™ Plus, il loro dispositivo di stimolazione del nervo vago di nuova generazione (nVNS). L'obiettivo della partnership è aumentare la consapevolezza sui benefici del dispositivo per il miglioramento del sonno e il sollievo dallo stress.
Truvaga è un dispositivo portatile per il benessere che stimola il nervo vago con sessioni di due minuti, aiutando gli utenti a ottenere un sonno più ristoratore e momenti di rilassamento senza ricorrere a farmaci. La collaborazione prevede spot radiofonici e campagne digitali, sfruttando l'esperienza NFL e il background da broadcaster di Buttle per mostrare come Truvaga supporti la gestione dello stress e la qualità del sonno.
electroCore (NASDAQ: ECOR) ha anunciado una alianza con el ex linebacker de los New York Jets Greg Buttle para promocionar Truvaga™ Plus, su dispositivo de estimulación vagal de nueva generación (nVNS). La asociación busca dar a conocer los beneficios del dispositivo para mejorar el sueño y aliviar el estrés.
Truvaga es un dispositivo portátil de bienestar que estimula el nervio vago en sesiones de dos minutos, ayudando a los usuarios a lograr un sueño más reparador y relajación sin medicación. La colaboración incluye cuñas de radio y campañas digitales, aprovechando la experiencia en la NFL y la trayectoria en medios de Buttle para mostrar cómo Truvaga ayuda a manejar el estrés y mejorar la calidad del sueño.
electroCore (NASDAQ: ECOR)는 전 뉴욕 제츠 라인배커 그렉 버틀과 제너레이션 업그레이드된 미주신경 자극기(nVNS)인 Truvaga™ Plus 홍보를 위한 파트너십을 발표했습니다. 이번 협력은 수면 개선과 스트레스 완화에 대한 기기 효능을 알리는 것이 목적입니다.
Truvaga는 2분 세션으로 미주신경을 자극하는 휴대용 웰니스 기기로, 약물 없이도 더 나은 수면과 이완을 돕습니다. 이번 파트너십에는 라디오 광고와 디지털 캠페인이 포함되며, 버틀의 NFL 경력과 방송 경험을 활용해 Truvaga가 스트레스 관리와 수면 질 개선에 어떻게 기여하는지 보여줄 예정입니다.
electroCore (NASDAQ: ECOR) a annoncé un partenariat avec l'ancien linebacker des New York Jets Greg Buttle pour promouvoir Truvaga™ Plus, leur dispositif de stimulation du nerf vague de nouvelle génération (nVNS). Ce partenariat vise à sensibiliser le public aux bienfaits du dispositif pour améliorer le sommeil et réduire le stress.
Truvaga est un appareil de bien-être portable qui stimule le nerf vague lors de sessions de deux minutes, aidant les utilisateurs à retrouver un sommeil plus réparateur et de la détente sans recours aux médicaments. Le partenariat inclut des spots radio et des campagnes digitales, s'appuyant sur l'expérience NFL et le parcours médiatique de Buttle pour montrer comment Truvaga favorise la gestion du stress et la qualité du sommeil.
electroCore (NASDAQ: ECOR) hat eine Partnerschaft mit dem ehemaligen Linebacker der New York Jets Greg Buttle angekündigt, um Truvaga™ Plus zu bewerben – ihr neuestes Vagusnervstimulationsgerät (nVNS). Ziel der Zusammenarbeit ist es, die Bekanntheit der Vorteile des Geräts für besseren Schlaf und Stressabbau zu steigern.
Truvaga ist ein tragbares Wellnessgerät, das den Vagusnerv in zwei Minuten langen Sitzungen stimuliert und Anwendern zu erholsameren Schlaf- und Entspannungsphasen ohne Medikamente verhilft. Die Partnerschaft umfasst Radiospots und digitale Kampagnen und nutzt Buttles NFL-Erfahrung sowie seine Tätigkeit als Kommentator, um zu zeigen, wie Truvaga Stressbewältigung und Schlafqualität unterstützt.
- None.
- None.
ROCKAWAY, N.J., Sept. 04, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today its partnership with Greg Buttle, former New York Jets linebacker and NFL star, to help raise awareness of Truvaga™ Plus, the Company’s next-generation handheld vagus nerve stimulation (nVNS) device designed to promote calm, clarity, and better sleep.
As a standout NFL player and respected sports broadcaster, Mr. Buttle knows firsthand the critical role that rest, recovery, and mental focus play in performance both on and off the field. By teaming up with electroCore, Mr. Buttle will share how Truvaga’s innovative, drug-free technology enables users to relax, recharge, and improve sleep quality in sessions that last just two minutes each.
“As an NFL linebacker, I had to be sharp, fast, and ready to hit every play. But you can’t bring that energy if you’re dragging from a bad night’s sleep. That’s why I use Truvaga. Just two minutes with this handheld device calms my body, quiets my mind, and sets me up for real rest, so I wake up recharged and ready to go,” said Greg Buttle. “That’s why I’m excited to partner with electroCore. This device has been a game-changer for me, helping me get the restorative sleep I need.”
Truvaga is a portable, easy-to-use wellness device that gently stimulates the vagus nerve, helping the body shift out of “fight or flight” mode into a state of balance. Backed by over 20 years of research in bioelectronic medicine, the technology is designed to naturally support stress management, relaxation, and deeper sleep without medication or drug-like side effects.
“We’re thrilled to welcome Greg Buttle to the Truvaga family,” said Kelly Benning, Senior Vice President of Truvaga at electroCore. “Greg’s leadership, credibility, and commitment to wellness and overall performance make him an ideal partner as we continue our mission making vagus nerve stimulation accessible to anyone seeking a natural way to feel calmer, think clearer, and sleep better.”
The partnership includes a series of radio spots and digital campaigns designed to engage fans, highlight the importance of stress management, and showcase Truvaga’s role in achieving peak wellness.
Made in the USA and backed by more than 20 years of research in bioelectronic medicine, Truvaga offers a natural approach to stress relief, clarity, and better sleep. For more information on Truvaga and to try it risk-free, visit www.Truvaga.com.
About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic technology company whose mission is to improve health and quality of life through innovative non-invasive bioelectronic technologies. The Company’s two leading prescription products, gammaCore non-invasive vagus nerve stimulation (nVNS) and Quell neurostimulator, treat chronic pain syndromes through non-invasive neuromodulation technology. Additionally, the company commercializes its handheld, and personal use Truvaga and TAC-STIM nVNS products utilizing bioelectronic technologies to promote general wellness and human performance.
For more information, visit www.electrocore.com.
About Truvaga Plus
Truvaga Plus is a revolutionary handheld vagus nerve stimulator that utilizes the company’s proven technology to quickly and gently activate the vagus nerve. It’s designed to work with the body to balance the nervous system to feel calmer, think clearer, and sleep better. Truvaga Plus is intended for general health and wellness purposes only and is not intended to diagnose, cure, mitigate, treat, or prevent any disease.
For more information, please visit www.truvaga.com.
Forward-Looking Statements
This press release and other written and oral statements made by representatives of electroCore may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements about the anticipated results from partnering with iHeartRadio and Greg Buttle, the benefits of Truvaga Plus, the Company’s future business strategies, growth opportunities, prospects, product development, and market expansion, and other statements that are not historical in nature, particularly those that utilize terminology such as “anticipates,” “will,” “expects,” “believes,” “intends,” and other words of similar meaning, derivations of such words and the use of future dates. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the ability to use strategic partnerships to provide more accessibility to those looking to purchase our consumer devices, the inherent uncertainties associated with developing new products or technologies, the ability to commercialize its products, electroCore’s results of operations and financial performance, inflation and currency fluctuations, and any expectations electroCore may have with respect thereto, competition in the industry in which electroCore operates and overall economic and market conditions. Any forward-looking statements are made as of the date of this press release, and electroCore assumes no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in the forward-looking statements, except as required by law. Investors should consult all of the information set forth herein and should also refer to the risk factor disclosure set forth in the reports and other documents electroCore files with the SEC available at www.sec.gov.
Contacts:
ECOR Investor Relations
(973) 302-9253
investors@electrocore.com
ECOR Media Relations
(973) 435-8354
media-inquiries@electrocore.com
FAQ
What is the new partnership between electroCore (NASDAQ: ECOR) and Greg Buttle?
How does electroCore's Truvaga Plus device work?
What are the main benefits of electroCore's Truvaga Plus?
Where is electroCore's Truvaga Plus device manufactured?
